ANEBULO PHARMACEUTICALS, INC. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
ANEBULO PHARMACEUTICALS, INC. (ANEB) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $0 for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-29.
Financial Statements › Expense Statement › Interest Expense
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2025-09-29
- ANEBULO PHARMACEUTICALS, INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2025 was $0.00.
- ANEBULO PHARMACEUTICALS, INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2024 was $0.00.
- ANEBULO PHARMACEUTICALS, INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2023 was $0.00.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month |
|---|---|
| 2025-06-30 | $0.00 10-K · filed 2025-09-29 |
| 2024-06-30 | $0.00 10-K · filed 2025-09-29 |
| 2023-06-30 | $0.00 10-K · filed 2024-09-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |